Proteome Analysis of Aflibercept Intervention in Experimental Central Retinal Vein Occlusion

Aflibercept is a frequently used inhibitor of vascular endothelial growth factor (VEGF) in the treatment of macular edema following central retinal vein occlusion (CRVO). Retinal proteome changes following aflibercept intervention in CRVO remain largely unstudied. Studying proteomic changes of aflib...

Descripción completa

Detalles Bibliográficos
Autores principales: Cehofski, Lasse Jørgensen, Kruse, Anders, Alsing, Alexander Nørgaard, Sejergaard, Benn Falch, Nielsen, Jonas Ellegaard, Schlosser, Anders, Sorensen, Grith Lykke, Grauslund, Jakob, Honoré, Bent, Vorum, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182497/
https://www.ncbi.nlm.nih.gov/pubmed/35684299
http://dx.doi.org/10.3390/molecules27113360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182497/
https://www.ncbi.nlm.nih.gov/pubmed/35684299
http://dx.doi.org/10.3390/molecules27113360

Ejemplares similares